Abstract
No public abstract is available from the verified source records.
Gizachew Muluneh Amera, Giulia Canarutto, Alessia Bellina, Xhaferr Tanushi, Deborah Sirch, Vito Giuseppe D'Agostino, Gianluca Tell, Silvano Piazza
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The nucleolus: an emerging target for cancer therapy
10.1016/j.molmed.2013.07.005 · 2013
Hallmarks of cancer: the next generation
10.1016/j.cell.2011.02.013 · 2011
Surveillance of tumour development: the relationship between tumour-associated RNAs and ribonucleases
10.3389/fphar.2019.01019 · 2019
Targeting the RNA-binding protein hur as potential thera-peutic approach for neurological disorders: focus on amyotrophic lateral sclerosis (ALS), spinal muscle atrophy (SMA) and multiple sclerosis
10.3390/ijms221910394 · 2021
10.1093/eurheartj/ehw567
10.1093/eurheartj/ehw567
10.1016/j.dnarep.2017.06.008
10.1016/j.dnarep.2017.06.008
Nucleophosmin interaction with APE1: insights into DNA repair regulation
10.1016/j.dnarep.2020.102809 · 2020
Revisiting two decades of research focused on targeting APE1 for cancer therapy: the pros and cons
10.3390/cells12141895 · 2023
APE1/Ref-1-one target with multiple indications: emerging aspects and new directions HHS public access
2021
10.1016/j.tins.2015.02.003
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1016/j.tins.2015.02.003
Apurinic/apyrimidinic endodeoxyribonuclease 1 modulates RNA G-quadruplex folding of miR-92b and controls its expression in cancer cells
10.1073/pnas.2317861121 · 2024
A phase I study of the APE1 protein inhibitor APX3330 in patients with advanced solid tumors
10.1200/jco.2019.37.15_suppl.3097 · 2025
10.1016/j.drudis.2020.10.015
10.1016/j.drudis.2020.10.015
CTC enumeration and characterization as a pharmacodynamic marker in the phase I clinical study of APX3330, an APE1/Ref-1 inhibitor, in patients with advanced solid tumors
10.1200/jco.2019.37.15_suppl.e14531 · 2019
Knockout and inhibition of Ape1: roles of Ape1 in base excision DNA repair and modulation of gene expression
10.3390/antiox11091817 · 2022
Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing parkin-mediated mitophagy
2019
AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models
10.1093/nar/gkab1061 · 2022
AlphaFold protein structure database 2025: a redesigned interface and updated structural coverage
10.1093/nar/gkaf1226 · 2026
AlphaFold protein structure database and 3D-beacons: new data and capabilities
10.1016/j.jmb.2025.168967 · 2025
Automated minimization of steric clashes in protein structures
10.1002/prot.22879 · 2011
Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8
10.1002/prot.22570 · 2009
Verification of protein structures: patterns of nonbonded atomic interactions
10.1002/pro.5560020916 · 1993
PROCHECK: a program to check the stereochemical quality of protein structures
10.1107/s0021889892009944 · 1993
Unresolved referenced work
1997
MolProbity: more and better reference data for improved all-atom structure validation
10.1002/pro.3330 · 2018
Two divalent metal ions in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic mechanism
10.1006/jmbi.2001.4529 · 2001
ZINC 15 - ligand discovery for everyone
10.1021/acs.jcim.5b00559 · 2015
AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings
10.1021/acs.jcim.1c00203 · 2021
The ClusPro web server for protein-protein docking
10.1038/nprot.2016.169 · 2017
10.1038/srep42717
10.1038/srep42717
DataWarrior: an open-source program for chemistry aware data visualization and analysis
10.1021/ci500588j · 2015
admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties
10.1093/nar/gkae298 · 2024
10.1093/bioinformatics/btae416
10.1093/bioinformatics/btae416
PLIP: fully automated protein-ligand interaction profiler
10.1093/nar/gkv315 · 2015
LigPlot+: multiple ligand-protein interaction diagrams for drug discovery
10.1021/ci200227u · 2011
Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers
10.1016/j.softx.2015.06.001 · 2015
Unresolved referenced work
2025
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
10.1021/jp003919d · 2001
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K
10.1021/jp003020w · 2001
Definition and testing of the GROMOS force-field versions 54A7 and 54B7
10.1007/s00249-011-0700-9 · 2011
Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4)
10.1080/07391102.2018.1468282 · doi-reference
The microRNA biology of the mammalian nucleus
10.1038/mtna.2014.40 · doi-reference
Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress
10.1038/s41598-019-46841-1 · doi-reference
The microRNA machinery
10.1007/978-3-319-22380-3_2 · doi-reference
Human AP-endonuclease (Ape1) activity on telomeric G4 structures is modulated by acetylatable lysine residues in the N-terminal sequence
10.1016/j.dnarep.2018.11.010 · doi-reference
APE1 condensation in nucleoli of non-cancer cells depends on rRNA transcription and forming G-quadruplex RNA structures
10.1093/nar/gkaf168 · doi-reference
Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions
10.1093/nar/gkq691 · doi-reference
The DNA-repair protein APE1 participates with hnRNPA2B1 to motif-enriched and prognostic miRNA secretion
10.1038/s41388-024-03039-8 · doi-reference
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
10.1002/jcc.21334 · doi-reference
Remote on–off switching of protein activity by intrinsically disordered region
10.1038/s41594-025-01585-7 · doi-reference
Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1
10.1111/cbdd.12826 · doi-reference
APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process
10.1128/mcb.01337-08 · doi-reference
Identification of apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA
10.1093/nar/gkp275 · doi-reference
A new APE1/Ref-1-dependent pathway leading to reduction of NF-κB and AP-1, and activation of their DNA-binding activity
10.1093/nar/gkn416 · doi-reference
The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
10.1089/ars.2005.7.367 · doi-reference
10.1038/emm.2014.42
10.1038/emm.2014.42 · doi-reference
A review on protein-protein interaction network of APE1/Ref-1 and its associated biological functions
10.1002/cbf.3100 · doi-reference
Bioconductor: open software development for computational biology and bioinformatics
10.1186/gb-2004-5-10-r80 · doi-reference
Metadynamics as a tool for exploring free energy landscapes of chemical reactions
10.1021/ar040198i · doi-reference
G-mmpbsa -a GROMACS tool for high-throughput MM-PBSA calculations
10.1021/ci500020m · doi-reference
The ACPYPE web server for small-molecule MD topology generation
10.1093/bioinformatics/btad350 · doi-reference
A novel approach for deriving force field torsion angle parameters accounting for conformation-dependent solvation effects
10.1021/ct3001987 · doi-reference
Testing and validation of the automated topology builder (ATB) version 2.0: prediction of hydration free enthalpies
10.1007/s10822-014-9713-7 · doi-reference